Merial Launches New Web Site for Equine West Nile Virus Vaccine
Equine West Nile Information
Merial announces the launch of EquineWNV.com, an interactive web site that offers comprehensive information about Recombitek Equine West Nile Virus vaccine. Aimed at horse owners and veterinarians, this site offers vaccination information, scientific research data and answers to frequently asked questions.
Unique to the site is animation illustrating the science behind recombinant technology, which makes the vaccine possible. Offered for the first time on the Internet, The Science Behind the Protection simulation gives viewers a firsthand look at this exciting technology, and helps educate horse owners and veterinarians about recombinant technology.
Recombitek Equine West Nile Virus vaccine offers fast-acting, long-lasting protection against West Nile Virus in horses. This vaccine offers fast-acting, long-lasting protection against West Nile Virus in horses. This vaccine is proven effective for na´ve horses and those previously vaccinated for WNV. It is also safe to use on foals. The vaccine is available in both 10x1 and 5x5 dose presentations. Contact Merial at 1-888-MERIAL-1 for more information, or see www.EquineWNV.com.
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 6,000 people and operates in more than 150 countries worldwide. Its 2004 sales were in excess of $1.8 million. Merial Limited is a joint venture between Merck & Co. and sanofi-aventis. For more information, please see www.merial.com.